|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date15 Sep 2023 |
100 Clinical Results associated with Biocon Biologics, Inc.
0 Patents (Medical) associated with Biocon Biologics, Inc.
100 Deals associated with Biocon Biologics, Inc.
100 Translational Medicine associated with Biocon Biologics, Inc.